34299330|t|Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization.
34299330|a|The ability of endocannabinoid (eCB) to change functional microglial phenotype can be explored as a possible target for therapeutic intervention. Since the inhibition of fatty acid amide hydrolase (FAAH), the main catabolic enzyme of anandamide (AEA), may provide beneficial effects in mice model of Alzheimer's disease (AD)-like pathology, we aimed at determining whether the FAAH inhibitor URB597 might target microglia polarization and alter the cytoskeleton reorganization induced by the amyloid-beta peptide (Abeta). The morphological evaluation showed that Abeta treatment increased the surface area of BV-2 cells, which acquired a flat and polygonal morphology. URB597 treatment partially rescued the control phenotype of BV-2 cells when co-incubated with Abeta. Moreover, URB597 reduced both the increase of Rho protein activation in Abeta-treated BV-2 cells and the Abeta-induced migration of BV-2 cells, while an increase of Cdc42 protein activation was observed in all samples. URB597 also increased the number of BV-2 cells involved in phagocytosis. URB597 treatment induced the polarization of microglial cells towards an anti-inflammatory phenotype, as demonstrated by the decreased expression of iNOS and pro-inflammatory cytokines along with the parallel increase of Arg-1 and anti-inflammatory cytokines. Taken together, these data suggest that FAAH inhibition promotes cytoskeleton reorganization, regulates phagocytosis and cell migration processes, thus driving microglial polarization towards an anti-inflammatory phenotype.
34299330	0	26	Fatty Acid Amide Hydrolase	Gene	14073
34299330	28	32	FAAH	Gene	14073
34299330	115	130	endocannabinoid	Chemical	MESH:D063388
34299330	132	135	eCB	Chemical	MESH:D063388
34299330	270	296	fatty acid amide hydrolase	Gene	14073
34299330	298	302	FAAH	Gene	14073
34299330	334	344	anandamide	Chemical	MESH:C078814
34299330	346	349	AEA	Chemical	-
34299330	386	390	mice	Species	10090
34299330	400	419	Alzheimer's disease	Disease	MESH:D000544
34299330	421	423	AD	Disease	MESH:D000544
34299330	477	481	FAAH	Gene	14073
34299330	492	498	URB597	Chemical	MESH:C500528
34299330	614	619	Abeta	Gene	11820
34299330	663	668	Abeta	Gene	11820
34299330	709	713	BV-2	CellLine	CVCL:0182
34299330	769	775	URB597	Chemical	MESH:C500528
34299330	829	833	BV-2	CellLine	CVCL:0182
34299330	863	868	Abeta	Gene	11820
34299330	880	886	URB597	Chemical	MESH:C500528
34299330	942	947	Abeta	Gene	11820
34299330	956	960	BV-2	CellLine	CVCL:0182
34299330	975	980	Abeta	Gene	11820
34299330	1002	1006	BV-2	CellLine	CVCL:0182
34299330	1035	1040	Cdc42	Gene	12540
34299330	1089	1095	URB597	Chemical	MESH:C500528
34299330	1125	1129	BV-2	CellLine	CVCL:0182
34299330	1162	1168	URB597	Chemical	MESH:C500528
34299330	1240	1252	inflammatory	Disease	MESH:D007249
34299330	1311	1315	iNOS	Gene	18126
34299330	1324	1346	inflammatory cytokines	Disease	MESH:D000080424
34299330	1383	1388	Arg-1	Gene	11846
34299330	1398	1420	inflammatory cytokines	Disease	MESH:D000080424
34299330	1462	1466	FAAH	Gene	14073
34299330	1622	1634	inflammatory	Disease	MESH:D007249
34299330	Association	MESH:D000544	14073
34299330	Positive_Correlation	MESH:C500528	11846
34299330	Negative_Correlation	MESH:C500528	18126
34299330	Negative_Correlation	MESH:C500528	14073
34299330	Positive_Correlation	MESH:C500528	12540
34299330	Association	MESH:D007249	14073
34299330	Negative_Correlation	MESH:C500528	11820
34299330	Negative_Correlation	MESH:C500528	MESH:D007249
34299330	Association	MESH:C078814	14073
34299330	Negative_Correlation	MESH:C500528	MESH:D000080424

